This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Digging into the topline data from Iveric Bio's Zimura GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
Ticker(s): ISEE, APLSWho's the expert?
Institution: UC Davis
- Professor of Ophthalmology at UC Davis.
- Manages ~400 patients with wet-AMD.
- Leads a translational research program studying age-related macular degeneration (AMD) and other retinal diseases.
- Research focuses include ocular imaging technologies, gene editing and delivery, and animal models of retinal disease.
Interview GoalThis conversation will focus on the recent data on Zimura and how this compares with Apellis' pegcetacoplan (EMPAVELI) for patients with GA.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
